ImpediMed Announced Medicare Payment for New L-Dex ® Classification I Code

BRISBANE, Australia & SAN DIEGO–(BUSINESS WIRE)– ImpediMed (ASX: IPD) is happy to reveal today the Centers for Medicare and Medicaid Services (CMS … innovations for use in the non-invasive professional assessment and monitoring of fluid status.See Original Post Genetic Alternative Evaluation Platform helps competence exchange.Cartagenia, a leader in offering hereditary labs and clinicians with software-based workflow support for alternative assessment … by the National Person Genome Research Institute(NHGRI), the NIH Office of Rare Diseases Research and the NIH Medical Center.See Original Short article Cartagenia Introduces Advanced Genetic Variant Evaluation Platform for NIH Undiagnosed Illness Program Oct. 30, 2014/ PRNewswire/– Cartagenia, a leader in providing genetic laboratories and clinicians with software-based

operations support for alternative evaluation … at the National Institutes of Health(NIH), the Undiagnosed Diseases Program(UDP), a medical … See Original Article

By |November 12th, 2014|NCAS|0 Comments

About the Author:

Leave A Comment

seventeen − 12 =